Frontlight ResearchEarly access
Trial site
Arizona Oncology Associates
- 5running trials
- 10closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Cervical cancer3 trials
- Colorectal cancer3 trials
- Endometrial cancer3 trials
- Melanoma3 trials
- Gastric and oesophageal cancer2 trials
- Kidney cancer2 trials
- Multiple myeloma2 trials
- Myelodysplastic syndromes2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Acute myeloid leukaemia1 trial
- and 8 more
- Phase
- Phase 26 trials
- Phase 33 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Terminated5 trials
- Active, not recruiting4 trials
- Completed4 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Regeneron Pharmaceuticals2 trials
- Actuate Therapeutics Inc.1 trial
- Daiichi Sankyo1 trial
- Hemavant Sciences GmbH1 trial
- Incyte Corporation1 trial
- and 9 more
Running trials
Recruiting
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
Closed trials
Recruiting
Terminated
Terminated
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
Completed
Completed
XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer
Completed
Terminated
Terminated
Terminated
A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026